£84.49

Springer Advances in Cancer Biomarkers: From biochemistry to clinic for a critical revision: 867 (Advances in Experimental Medicine and Biology, 867)

Price data last checked 62 day(s) ago - refreshing...

View at Amazon

Price History & Forecast

Last 29 days • 29 data points (No recent data available)

Historical
Generating forecast...
£84.49 £79.76 £80.79 £81.82 £82.86 £83.89 £84.92 25 January 2026 01 February 2026 08 February 2026 15 February 2026 22 February 2026

Price Distribution

Price distribution over 29 days • 2 price levels

Days at Price
Current Price
21 days 8 days · current 0 5 11 16 21 £80 £84 Days at Price

Price Analysis

Most common price: £80 (21 days, 72.4%)

Price range: £80 - £84

Price levels: 2 different prices over 29 days

Description

At present there are a growing number of biomolecules under investigation to understand their potential role as cancer biomarker for diagnostic, prognostic and therapeutic purposes. Intriguingly, the state of art on cancer biomarkers research shows interesting and promising results together to clamorous failures. Also from a clinical point of view, there are contradictory results on routine clinical use of the present cancer biomarkers. Some patients may be simply monitored in their course by a periodic blood sample, but sometimes this monitoring shows dramatic limits. A lot of patients show serious and extensive relapses without significant change in serum concentrations of biomarkers tested. Often the physician who should utilize these biomarker does not entirely know their limits and the total potential applications as well and sometimes this knowledge is influenced by economical and marketing strategies. This limited and “polluted” knowledge may have dramatic consequences for patient. The aim of this book is to diffuse all aspects of cancer biomarkers, from their biochemical peculiarities to all clinical implications by passing through their physiology and pathophysiology. This critical approach towards old and new cancer biomarkers should foster a deepened and useful understanding of the diagnostic and prognostic index of these fundamental parameters of laboratory medicine and in the same time facilitating the research of new and more sensitive-specific signals of the cancer cell proliferation.

Product Specifications

Barcode

No barcode data available

Similar Products You Might Like

Molecular Biomarkers for Cancer Diagnosis and Therapy
96% match

Molecular Biomarkers for Cancer Diagnosis and Therapy

Springer

£121.71 29 Jan 2026
Cancer Biomarkers in Diagnosis and Therapeutics
96% match

Cancer Biomarkers in Diagnosis and Therapeutics

£118.00 13 Jan 2026
Cancer Biomarkers: Clinical Aspects and Laboratory Determination
95% match

Cancer Biomarkers: Clinical Aspects and Laboratory Determination

Elsevier

£109.37 09 Mar 2026
Cancer Biomarkers: Minimal and Noninvasive Early Diagnosis and Prognosis
95% match

Cancer Biomarkers: Minimal and Noninvasive Early Diagnosis and Prognosis

CRC Press

£103.58 17 Feb 2026
Cancer Biomarkers: Minimal and Noninvasive Early Diagnosis and Prognosis
95% match

Cancer Biomarkers: Minimal and Noninvasive Early Diagnosis and Prognosis

CRC Press

£146.42 12 Jan 2026
Springer - Cancer Biomarkers in Body Fluids: Principles
95% match

Springer - Cancer Biomarkers in Body Fluids: Principles

Springer

£113.09 04 Mar 2026
CRC Press Cancer Biomarkers - Molecular Marker Research Book
95% match

CRC Press Cancer Biomarkers - Molecular Marker Research Book

CRC Press

£125.00 08 Apr 2026
Cancer Biomarkers (Cancer Etiology, Diagnosis and Treatments)
94% match

Cancer Biomarkers (Cancer Etiology, Diagnosis and Treatments)

£16.21 08 Mar 2026
Research on New Generation Tumor Markers - Nova Science Publishers
94% match

Research on New Generation Tumor Markers - Nova Science Publishers

£105.35 18 Apr 2026
Cancer Biomarkers in Body Fluids: Principles
94% match

Cancer Biomarkers in Body Fluids: Principles

Springer

£109.24 09 Mar 2026
Cancer Biomarkers in Body Fluids: Biomarkers in Circulation
94% match

Cancer Biomarkers in Body Fluids: Biomarkers in Circulation

Springer

£131.72 09 Mar 2026
Circulating Tumor Cells in Breast Cancer Metastatic Disease: 1220 (Advances in Experimental Medicine and Biology, 1220)
94% match

Circulating Tumor Cells in Breast Cancer Metastatic Disease: 1220 (Advances in Experimental Medicine and Biology, 1220)

Springer

£75.66 01 Mar 2026
Molecular Biology of Human Cancers
94% match

Molecular Biology of Human Cancers

£76.67 12 Jan 2026
Molecular Biology of Human Cancers
94% match

Molecular Biology of Human Cancers

£96.11 13 Jan 2026
Biomarkers in Breast Cancer (Cancer Drug Discovery and Development)
94% match

Biomarkers in Breast Cancer (Cancer Drug Discovery and Development)

Humana

£144.17 12 Jan 2026
Biomarkers in Cancer (Biomarkers in Disease: Methods, Discoveries and Applications)
94% match

Biomarkers in Cancer (Biomarkers in Disease: Methods, Discoveries and Applications)

Springer

£220.43 23 Jan 2026
Molecular Testing in Cancer
94% match

Molecular Testing in Cancer

Springer

£86.14 09 Mar 2026
Advances in Cancer Biomarkers Research
93% match

Advances in Cancer Biomarkers Research

Academic Press

£117.08 09 Mar 2026
Stress Response Pathways in Cancer: From Molecular Targets to Novel Therapeutics
93% match

Stress Response Pathways in Cancer: From Molecular Targets to Novel Therapeutics

Springer

£107.67 07 Jan 2026
Molecular Oncology: Underlying Mechanisms and Translational Advancements
93% match

Molecular Oncology: Underlying Mechanisms and Translational Advancements

Springer

£82.73 09 Mar 2026
Humana Tumor Biomarker Discovery: Methods and Protocols 520
93% match

Humana Tumor Biomarker Discovery: Methods and Protocols 520

Humana

£102.16 20 Apr 2026
Metabolism in Cancer: 207 (Recent Results in Cancer Research, 207)
93% match

Metabolism in Cancer: 207 (Recent Results in Cancer Research, 207)

Springer

£98.49 11 Jan 2026
Cancer Genomics: Molecular Classification, Prognosis and Response Prediction
93% match

Cancer Genomics: Molecular Classification, Prognosis and Response Prediction

Springer

£132.00 12 Jan 2026
From Molecular to Modular Tumor Therapy:: Tumors are Reconstructible Communicatively Evolving Systems: 3 (The Tumor Microenvironment, 3)
93% match

From Molecular to Modular Tumor Therapy:: Tumors are Reconstructible Communicatively Evolving Systems: 3 (The Tumor Microenvironment, 3)

Springer

£149.65 30 Mar 2026